HSP60-Derived Peptide as an LPS/TLR4 Modulator: An in silico Approach

Abstract

As a part of innate immunity mechanisms, the Toll-like receptor (TLR) signaling pathway serves as one of the mainstay lines of defense against pathogenic microorganisms and cell dysfunction. Nevertheless, TLR overactivation induces a systemic proinflammatory environment compromising organ function or causing the patient’s death. TLRs modulators, specially those focused for TLR4, remain a promising approach for inflammatory diseases treatment, being peptide-based therapy a trendy approach. Heat shock protein 60 (HSP60) not only plays a pivotal role in the development of several maladies with strong inflammatory components but also HSP60 peptides possess anti-inflammatory properties in TLR4-mediated diseases, such as diabetes, arthritis, and atherosclerosis. The experimental treatment using HSP60 peptides has proven to be protective in preclinical models of the heart by hampering inflammation and modulating the activity of immune cells. Nonetheless, the effect that these peptides may exert directly on cells that express TLR and its role to inhibit overactivation remain elusive. The aim of this study is to evaluate by molecular docking, a 15 amino acid long-HSP60 peptide (Peptide-2) in the lipopolysaccharide (LPS) binding site of TLR4/MD2, finding most Peptide-2 resulting conformations posed into the hydrophobic pocket of MD2. This observation is supported by binding energy obtained for the control antagonist Eritoran, close to those of Peptide-2. This last does not undergo drastic structural changes, moving into a delimited space, and maintaining the same orientation during molecular dynamics simulation. Based on the two computational techniques applied, interaction patterns were defined for Peptide-2. With these results, it is plausible to propose a peptidic approach for TLR4 modulation as a new innovative therapy to the treatment of TLR4-related cardiovascular diseases.

Molecular Challenges and Opportunities in Climate Change-Induced Kidney Diseases

“…For this reason, cellular levels of HSPs may increase in heatstroke conditions (as previously discussed) while remaining low in the absence of stressors. Therefore, HSPs play a major role in the biological response to stress, and its modulation and understanding is of interest in diverse pathologies [ 93 , 94 ].…”

Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting

“…Recently, an Hsp60-derived peptide was also tested in a silico model as a protective tool against inflammation [82]. Previously published results, dating back to 1996, showed that the Hsp60 peptide p277 was able to arrest autoimmune diabetes induced by the toxin Streptozotocin [83].…”

Fucoidan’s Molecular Targets: A Comprehensive Review of Its Unique and Multiple Targets Accounting for Promising Bioactivities Supported by In Silico Studies

“…During endotoxic signalling, the Phe126 residue in the hydrophobic pocket of MD-2 represents the "molecular switch". This residue is linked to TLR4 activation and allosterically triggers a conformational shift in a ligand-dependent way [185,186]. Others have reported that during activation of TLR4 via endotoxin, Phe121, Phe126 and Tyr131, played a crucial role in human MD-2 [187].…”